FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Petra Steinacker

Research Profile

Disorders

Concepts & Ideas

Biological Markers

Chemicals & Drugs

Procedures

Occupations

Proteomics

Anatomy

Brain

Co-author Network

Publications

TOP 3
Stefan Lehnert; Martin Lenter; Patrick Oeckl; Boris Ferger; Bastian Hengerer; Sanna-Kaisa Herukka; Sarah Jesse; Wolfgang Rist; Hilkka Soininen; Petra Steinacker; Hayrettin Tumani; Markus Otto
iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia.
Sarah Jesse; Hans A Kretzschmar; Hasan Kulaksiz; Stefan Lehnert; Martin Lenter; Manuela Neumann; Boris Ferger; Bastian Hengerer; Sanna-Kaisa Herukka; Olaf Jahn; Lucilla Parnetti; Hilkka Soininen; Petra Steinacker; Saskia Tawfik; Hayrettin Tumani; Christine A F Von Arnim; Jens Wiltfang; Markus Otto
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.
Patrick Oeckl; Markus Otto; Petra Steinacker; Sarah Jesse; Hans A Kretzschmar; Stefan Lehnert; Albert C Ludolph; Boris Ferger
CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Petra Steinacker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Stefan Lehnert; Martin Lenter; Patrick Oeckl; Boris Ferger; Bastian Hengerer; Sanna-Kaisa Herukka; Sarah Jesse; Wolfgang Rist; Hilkka Soininen; Petra Steinacker; Hayrettin Tumani; Markus Otto
iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia.
Experimental neurology 2012;234(2):499-505.
2012: Sarah Jesse; Hans A Kretzschmar; Hasan Kulaksiz; Stefan Lehnert; Martin Lenter; Manuela Neumann; Boris Ferger; Bastian Hengerer; Sanna-Kaisa Herukka; Olaf Jahn; Lucilla Parnetti; Hilkka Soininen; Petra Steinacker; Saskia Tawfik; Hayrettin Tumani; Christine A F Von Arnim; Jens Wiltfang; Markus Otto
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.
PloS one 2012;7(11):e48783.
2012: Patrick Oeckl; Markus Otto; Petra Steinacker; Sarah Jesse; Hans A Kretzschmar; Stefan Lehnert; Albert C Ludolph; Boris Ferger
CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.
PloS one 2012;7(3):e32664.
2012: Markus Otto; Lucilla Parnetti; Axel Petzold; Pamela Shaw; Alexander Sherman; Petra Steinacker; Sigurd D Süssmuth; Charlotte Teunissen; Hayrettin Tumani; Martin Turner; Anna Wuolikainen; James Berry; Robert Bowser; Johannes Brettschneider; James Connor; Júlia Costa; Merit Cudkowicz; Jonathan Glass; Olaf Jahn; Stefan Lehnert; Albert Ludolph; Andrea Malaspina
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2012;13(1):1-10.
2011: Petra Steinacker; Alastair Aitken; Markus Otto
14-3-3 proteins in neurodegeneration.
Seminars in cell & developmental biology 2011;22(7):696-704.
2011: Brit Mollenhauer; Hermann Esselmann; Sigrun Roeber; Walter J Schulz-Schaeffer; Claudia Trenkwalder; Mirko Bibl; Petra Steinacker; Hans A Kretzschmar; Jens Wiltfang; Markus Otto
Different CSF β-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease.
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(5):691-7.
2011: Petra Steinacker; Hayrettin Tumani; Lubin Fang; Jens Kuhle; Albert C Ludolph; Markus Otto; Axel Petzold; Johannes Brettschneider
Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
PloS one 2011;6(8):e23600.
2010: Petra Steinacker; Andreas Hawlik; Stefan Lehnert; Olaf Jahn; Stephen Meier; E Görz; Kerstin Braunstein; Marija Krzovska; Birgit Schwalenstöcker; Sarah Jesse; Christian Pröpper; Tobias Böckers; Albert Ludolph; Markus Otto
Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis.
The American journal of pathology 2010;176(3):1409-20.
2010: Petra Steinacker; Hans Klafki; Stefan Lehnert; Sarah Jesse; Christine A F V Arnim; Hayrettin Tumani; Alice Pabst; Hans A Kretzschmar; Jens Wiltfang; Markus Otto
ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients.
Journal of Alzheimer's disease : JAD 2010;22(1):119-28.
2010: Sarah Jesse; Petra Steinacker; Stefan Lehnert; Martin Sdzuj; Lukas Cepek; Hayrettin Tumani; Olaf Jahn; Holger Schmidt; Markus Otto
A proteomic approach for the diagnosis of bacterial meningitis.
PloS one 2010;5(4):e10079.
2010: Petra Steinacker; Wolfgang Rist; Magdalena Swiatek-de Lange; Stefan Lehnert; Sarah Jesse; Alice Pabst; Hayrettin Tumani; Christine A F Von Arnim; Eva Mitrova; Hans A Kretzschmar; Martin Lenter; Jens Wiltfang; Markus Otto
Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.
Proteomics 2010;10(1):81-9.
2009: Petra Steinacker; Corinna Hendrich; Anne-Dorte Sperfeld; Sarah Jesse; Stefan Lehnert; Alice Pabst; Christine A F Von Arnim; Felix M Mottaghy; Ingo Uttner; Hayrettin Tumani; Albert Ludolph; Markus Otto
Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(9):1169-78.
2009: Sarah Jesse; Petra Steinacker; Lukas Cepek; Christine A F Von Arnim; Hayrettin Tumani; Stefan Lehnert; Hans A Kretzschmar; Michael Baier; Markus Otto
Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
Journal of Alzheimer's disease : JAD 2009;17(3):541-51.
2009: Sarah Jesse; Petra Steinacker; Stefan Lehnert; Frank Gillardon; Bastian Hengerer; Markus Otto
Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.
CNS neuroscience & therapeutics 2009;15(2):157-82.
2008: Petra Steinacker; Corinna Hendrich; Anne-Dorte Sperfeld; Sarah Jesse; Christine A F Von Arnim; Stefan Lehnert; Alice Pabst; Ingo Uttner; Hayrettin Tumani; Virginia M-Y Lee; John Q Trojanowski; Hans A Kretzschmar; Albert C Ludolph; Manuela Neumann; Markus Otto
TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Archives of neurology 2008;65(11):1481-7.
2007: Brit Mollenhauer; Mirko Bibl; H Esselmann; Petra Steinacker; Claudia Trenkwalder; Jens Wiltfang; Markus Otto
Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(7):919-27.
2007: Brit Mollenhauer; Petra Steinacker; Erik Bahn; Mirko Bibl; Peter Brechlin; Michael G Schlossmacher; Joseph J Locascio; Jens Wiltfang; Hans A Kretzschmar; Sigrid Poser; Claudia Trenkwalder; Markus Otto
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies.
Neuro-degenerative diseases 2007;4(5):366-75.
2007: Lukas Cepek; Peter Brechlin; Petra Steinacker; Brit Mollenhauer; Enrico Klingebiel; Mirko Bibl; Hans A Kretzschmar; Jens Wiltfang; Markus Otto
Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Dementia and geriatric cognitive disorders 2007;23(1):22-8.
2006: Brit Mollenhauer; Mirko Bibl; Hermann Esselmann; Petra Steinacker; Claudia Trenkwalder; Peter Brechlin; J Wiltfang; Markus Otto
Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation.
Journal of neurology, neurosurgery, and psychiatry 2006;77(10):1201-3.
2006: Brit Mollenhauer; Claudia Trenkwalder; Nicolas von Ahsen; Mirko Bibl; Petra Steinacker; Peter Brechlin; Jan Schindehuette; Sigrid Poser; Jens Wiltfang; Markus Otto
Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia.
Dementia and geriatric cognitive disorders 2006;22(3):200-8.
2006: Brit Mollenhauer; Mirko Bibl; Jens Wiltfang; Petra Steinacker; Barbara Ciesielczyk; Karin Neubert; Claudia Trenkwalder; Markus Otto
Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2006;44(2):192-5.
2005: Brit Mollenhauer; Mirko Bibl; Claudia Trenkwalder; Gerthild Stiens; Lukas Cepek; Petra Steinacker; Barbara Ciesielczyk; Karin Neubert; Jens Wiltfang; Hans A Kretzschmar; Sigrid Poser; Markus Otto
Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(7):933-48.
2005: Petra Steinacker; Petra Schwarz; Kerstin Reim; Peter Brechlin; Olaf Jahn; Hartmut Kratzin; Alastair Aitken; Jens Wiltfang; Adriano Aguzzi; Erik Bahn; Helen C Baxter; Nils Brose; Markus Otto
Unchanged survival rates of 14-3-3gamma knockout mice after inoculation with pathological prion protein.
Molecular and cellular biology 2005;25(4):1339-46.
2005: Lukas Cepek; Petra Steinacker; Brit Mollenhauer; Birgitt Wiese; Barbara Ciesielczyk; Mirko Bibl; Jens Wiltfang; Inga Zerr; Walter Schulz-Schaeffer; Hans A Kretzschmar; Sigrid Poser; Markus Otto
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Dementia and geriatric cognitive disorders 2005;19(5-6):376-82.
2005: Brit Mollenhauer; Lukas Cepek; Mirko Bibl; Jens Wiltfang; Walter Schulz-Schaeffer; Barbara Ciesielczyk; Manuela Neumann; Petra Steinacker; Hans A Kretzschmar; Sigrid Poser; Claudia Trenkwalder; Markus Otto
Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.
Dementia and geriatric cognitive disorders 2005;19(2-3):164-70.
2004: Petra Steinacker; Brit Mollenhauer; Mirko Bibl; Lukas Cepek; Hermann Esselmann; Peter Brechlin; Piotr Lewczuk; Sigrid Poser; Hans A Kretzschmar; Jens Wiltfang; Claudia Trenkwalder; Markus Otto
Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.
Neuroscience letters 2004;370(1):36-9.
2004: Piotr Lewczuk; Hermann Esselmann; Teja Wolfgang Groemer; Mirko Bibl; Juan Manuel Maler; Petra Steinacker; Markus Otto; Johannes Kornhuber; Jens Wiltfang
Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
Biological psychiatry 2004;55(5):524-30.
2003: Jens Wiltfang; Hermann Esselmann; Alexandr Smirnov; Mirko Bibl; Lukas Cepek; Petra Steinacker; Brit Mollenhauer; Katharina Buerger; Harald Hampel; Sabine Paul; Manuela Neumann; Manuel Maler; Inga Zerr; Johannes Kornhuber; Hans A Kretzschmar; Sigrid Poser; Markus Otto
Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Annals of neurology 2003;54(2):263-7.
2003: Peter Ratzka; Susanne Döhlinger; Lukas Cepek; Petra Steinacker; Sönke Arlt; Christian Jacobi; Andreas Schröter; Jens Wiltfang; Hilmar Prange; Hans A Kretzschmar; Sigrid Poser; Markus Otto
Different binding pattern of antibodies to prion protein on lymphocytes from patients with sporadic Creutzfeldt-Jakob disease.
Neuroscience letters 2003;343(1):29-32.
2002: Helen C Baxter; Janet R Fraser; Wing Gee Liu; J L Forster; Samuel J Clokie; Petra Steinacker; Markus Otto; Erik Bahn; Jens Wiltfang; Alastair Aitken
Specific 14-3-3 isoform detection and immunolocalization in prion diseases.
Biochemical Society transactions 2002;30(4):387-91.
2002: Markus Otto; Jens Wiltfang; Lukas Cepek; Manuela Neumann; Brit Mollenhauer; Petra Steinacker; Barbara Ciesielczyk; Walter Schulz-Schaeffer; Hans A Kretzschmar; Sigrid Poser
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.
Neurology 2002;58(2):192-7.
2000: Markus Otto; Hermann Esselmann; W Schulz-Shaeffer; Manuela Neumann; Andreas Schröter; Peter Ratzka; Lukas Cepek; Inga Zerr; Petra Steinacker; Otto Windl; Johannes Kornhuber; Hans A Kretzschmar; Sigrid Poser; Jens Wiltfang
Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Neurology 2000;54(5):1099-102.
1999: Jens Wiltfang; Markus Otto; Helen C Baxter; Monika Bodemer; Petra Steinacker; Erik Bahn; Inga Zerr; Johannes Kornhuber; Hans A Kretzschmar; Sigrid Poser; Eckart Rüther; Alastair Aitken
Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Journal of neurochemistry 1999;73(6):2485-90.